80wk Downtrend — falling+below (sma 1.49 vs px 0.98)
200wk Downtrend — falling+below (sma 2.31 vs px 0.98)
RS Breakdown — momZ +0.32 · low 0w×1.00 · vs industry
About Rein Therapeutics Inc
Rein Therapeutics Inc., a biopharmaceutical company, focuses on developing medicines to address unmet medical needs in orphan pulmonary and fibrosis indications in the United States. The company's lead product candidate is LTI-03, a peptide, which is in Phase 2 clinical trial for the treatment of idiopathic pulmonary fibrosis (IPF). It also offers LTI-01, a proenzyme that has completed Phase 1b and Phase 2a clinical trials in LPE patients for the… Read full Trend Edge analysis →
Sector: Healthcare
Industry: Biotechnology
Exchange: NASDAQ
IPO Date: March 12, 1986
Headquarters: 12407 N. Mopac Expy., Austin, TX, United States, 78758
Hidden Gem: Yes — undiscovered relative to its market cap tier
Founder-Led: No
Key Metrics
Current Price
$0.98
Market Cap
$85.4M
Float
71.5M
Shares Outstanding
85.5M
vs. Analyst Target
+716.3% to analyst PT
Dividend Rate
None
Analyst Target Price
$8.00 (1 analysts)
Financial History
Annual Revenue & Earnings History
Year
Revenue
Net Income
Gross Profit
EBITDA
2020
N/A
-$21,157
N/A
-$20,333
2021
N/A
-$26,164
N/A
-$26,043
2022
N/A
-$27,329
N/A
-$27,160
2023
N/A
-$15,732
N/A
-$15,229
2024
N/A
-$62.9M
-$63,000
-$28.0M
2025
N/A
-$49.9M
-$1,000
-$50.6M
Recent Quarterly Revenue & Net Income
Quarter
Revenue
Net Income
Jun 2025
N/A
-$6.8M
Sep 2025
N/A
-$5.6M
Dec 2025
N/A
-$32.0M
Mar 2026
N/A
-$5.8M
Ownership & Float
Insider Ownership
5.5%
Institutional Ownership
24.6%
Short Float
0.4%
% of All Funds Holding
0.54%
Number of Funds Holding
44
Current Moving Averages
Trend Edge tracks near-term, medium-term, cyclical, and secular moving averages across weekly and monthly timeframes to identify trend structure at every horizon.
Timeframe
SMA
Value
Trend Context
Weekly
10-Week SMA
$1.02
Near-term / short-term trend
Weekly
40-Week SMA
$1.26
Medium-term trend
Weekly
80-Week SMA
$1.49
Cyclical trend (business cycle)
Weekly
200-Week SMA
$2.31
Secular trend (multi-year)
Monthly
10-Month SMA
$1.25
Near-term monthly trend
Monthly
20-Month SMA
$1.47
Medium-term monthly trend
Monthly
40-Month SMA
$2.18
Secular monthly trend
Volume Shelves — Support & Resistance
Trend Edge identifies volume shelves: price zones where historically elevated trading volume
creates structural support or resistance. A volume shelf forms when a disproportionate share of cumulative
volume was transacted at a specific price level, making it a high-conviction anchor for future price reactions.
Trend Edge's AI Consult feature delivers a comprehensive, multi-layer trade plan for Rein Therapeutics Inc
(RNTX) powered by Claude Opus — Anthropic's most capable AI model.
The analysis covers five layers:
technical analysis (near-term, medium-term, cyclical, and secular trend, momentum,
volume shelf support and resistance, breakout and breakdown signals),
qualitative analysis (business model, competitive moat, sector dynamics),
insider sentiment (buy and sell signals from executive and director transactions),
share stats analysis (institutional accumulation, fund positioning, short float squeeze potential), and
fundamental analysis (valuation, revenue growth, profit margin, earnings quality).
AI Consult synthesizes all five layers into a single bullish or bearish thesis with explicit entry, exit,
stop loss, and take profit levels — giving you a complete, AI-powered trade plan with defined risk/reward.
Whether you are building a long position, initiating a short, or looking for a reversal setup,
AI Consult identifies the highest-probability signal from the current trend.